Queensland Bauxite Limited (ASX:QBL) is proud to report on Medical Cannabis Limited (MCL)'s progress with a major milestone achieved this week. 20 tonnes of certified low THC hemp seed for sowing has been secured so that MCL will be able to grow enough low THC cannabis.
Regeneus Ltd (ASX:RGS) , a clinical-stage regenerative medicine company, today announced that a preclinical post-operative pain study has shown that topical application of Sygenus, has significantly greater and longer lasting analgesic effect than an injection of morphine.
Queensland Bauxite Limited (ASX:QBL) is pleased to announce preliminary findings in relation to cannabinoid testing performed by its subsidiary Medical Cannabis Limited of some of MCL's low THC Cannabis cultivars. (THC is tetrahydrocannabinol Delta 9, a medical compound produced by Cannabis plants).
Anatara Lifesciences Limited (ASX:ANR) has today undertaken to extend by 12 months the expiry date of 250,000 Options which Anatara issued to the Pork Cooperative Research Centre in 2015.
The Board of Queensland Bauxite (ASX:QBL) is pleased to announce that the Department of Natural Resources and Mines has now formally approved the work programme intended under the MDL.
The following investment report by Edison titled 'Preparing for a clinical licence deal in Japan' has been published.
The Board of Queensland Bauxite (ASX:QBL) is delighted to announce that Mineral Development License approval has been progressed for the South Johnstone Bauxite Project at Camp Creek in Queensland with the important decision received today from the DEHP to approve the amendment to our previous Environmental Authority, to allow for the work programme intended under the MDL.
